|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1996-7-9
|
|
pubmed:abstractText |
The aim of the study was to define the prognostic role of the metastasis suppressor gene, nm23, in 106 primary ovarian cancer patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
334-42
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:8636741-Blotting, Northern,
pubmed-meshheading:8636741-Blotting, Western,
pubmed-meshheading:8636741-Disease-Free Survival,
pubmed-meshheading:8636741-Female,
pubmed-meshheading:8636741-Genes, Tumor Suppressor,
pubmed-meshheading:8636741-Humans,
pubmed-meshheading:8636741-Immunohistochemistry,
pubmed-meshheading:8636741-Lymphatic Metastasis,
pubmed-meshheading:8636741-Middle Aged,
pubmed-meshheading:8636741-Ovarian Neoplasms,
pubmed-meshheading:8636741-Prognosis,
pubmed-meshheading:8636741-Receptor, Epidermal Growth Factor
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
nm23 in ovarian cancer: correlation with clinical outcome and other clinicopathologic and biochemical prognostic parameters.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, Catholic University, Rome, Italy.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
